<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02421627</url>
  </required_header>
  <id_info>
    <org_study_id>ZYS2015-01</org_study_id>
    <nct_id>NCT02421627</nct_id>
  </id_info>
  <brief_title>Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome</brief_title>
  <official_title>Study on the Mechanism of Moxibustion Effect on Treating Diarrhea-predominant Irritable Bowel Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Institute of Acupuncture, Moxibustion and Meridian</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Institute of Acupuncture, Moxibustion and Meridian</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To observe the safety and efficacy of moxibustion on diarrhea-predominant irritable bowel
      syndrome and evaluation by Magnetic Resonance Imaging (MRI).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. A randomized controlled trial

        2. Moxibustion treatment, placebo control

        3. To observe the safety and efficacy of moxibustion treatment versus placebo control

        4. Evaluation by structural MRI and resting state-functional MRI
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total efficacy (Adequate relief responder)</measure>
    <time_frame>4 years</time_frame>
    <description>The ratio of the number of responders and the total number of participants in each group. Adequate relief responder is the participant who considered effective treatment in the self-assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptom severity score (SSS)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bristol stool form scale (BSS)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life questionnaire (IBS-QOL)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital anxiety and depression score (HADS)</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rating anxiety scale</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-rating Depression Scale</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diarrhea frequency per day</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urgency of defecation</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety evaluation (Number of participants with treatment-related adverse events as assessed by CTCAE v4.0)</measure>
    <time_frame>4 years</time_frame>
    <description>Eg.moxibustion related burns, blistering, etc</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Brain structures （gray matter, white matter）MRI</measure>
    <time_frame>4 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>resting-state functional MRI</measure>
    <time_frame>4 years</time_frame>
    <description>Analysis with methods of regional homogeneity，ALFF/fALFF，functional connectivity.</description>
  </other_outcome>
  <other_outcome>
    <measure>Magnetic Resonance Spectroscopy (MRS)</measure>
    <time_frame>4 years</time_frame>
    <description>The ratio of glutamate complex (Glx) peak area and creatine ratio (Cr) of the cingulate cortex and insula.</description>
  </other_outcome>
  <other_outcome>
    <measure>Event-related potentials (ERP)</measure>
    <time_frame>4 years</time_frame>
    <description>Measurement of brain resting state energy atlas and the amplitude changes of each major components during the task and latency.</description>
  </other_outcome>
  <other_outcome>
    <measure>Intestinal microbiota changes</measure>
    <time_frame>4 years</time_frame>
    <description>Fecal microbiota changes</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Irritable Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>Moxibustion group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Acupoints: Tianshu (ST25，bilateral), Zusanli (ST36，bilateral);using mild-warm moxibustion，keep transcutaneous temperature maintained at 43 ℃ ± 1 ℃, 30min for each acupoint, once every other day, three times a week, a total of six weeks of moxibustion treatment. After the treatment, subjects were followed up in the 12 weeks and 18 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo moxibustion group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Acupoints: Tianshu (ST25，bilateral), Zusanli (ST36，bilateral);using mild-warm moxibustion，keep transcutaneous temperature maintained at 37 ℃ ± 1 ℃, 30min for each acupoint, once every other day, three times a week, a total of six weeks of moxibustion treatment. After the treatment, subjects were followed up in the 12 weeks and 18 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>moxibustion</intervention_name>
    <description>Mild-warm moxibustion is a type of moxa stick moxibustion that is performed by holding an ignited moxa stick a certain distance above the patient's skin, keeping the spot warm and making it reddened, but not burnt.The temperature maintained at 43 ± 1℃。</description>
    <arm_group_label>Moxibustion group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo moxibustion</intervention_name>
    <description>Placebo mild-warm moxibustion is a type of moxa stick moxibustion that is performed by holding an ignited moxa stick a certain distance above the patient's skin (farther than the real moxibustion), keeping the temperature maintained at 37 ± 1℃。</description>
    <arm_group_label>Placebo moxibustion group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diarrhea-predominant IBS patients who met the Rome III diagnostic criteria;

          2. Age 18-65 years old, male or female;

          3. Volunteered for the trial, signed the informed consent

        Exclusion Criteria:

          1. Intestinal organic disease;

          2. Constipation-predominant IBS;

          3. Alternating diarrhea and constipation IBS;

          4. Unstructured IBS;

          5. At the same time, application of smecta, dicetel, cisapride or traditional Chinese
             medicine;

          6. Combined liver, kidney, heart or mental disease patients;

          7. Under the age of 18 or above the age of 65 patients;

          8. Pregnant or lactating women.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huangan Wu, MD,PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai University of TCM</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chunhui Bao, MD,PhD</last_name>
    <phone>+86-21-64395973</phone>
    <email>baochunhui789@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Institute of Acupuncture, Moxibustion and Meridian</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chunhui Bao, PhD,MD</last_name>
      <phone>862164395973</phone>
      <email>baochunhui789@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shanghai Traditional Chinese Medicine-Integrated Hospital, Shanghai University of Traditional Chinese Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200082</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhihai Hu, MD</last_name>
      <phone>86-21-65415910</phone>
      <email>keyanzhenjiu@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yueyang Integrated Chinese and Western Medicine Hospital, Shanghai University of Traditional Chinese Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200437</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Li, MD</last_name>
      <phone>86-21-65161782</phone>
      <email>lj0806@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2015</study_first_submitted>
  <study_first_submitted_qc>April 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2015</study_first_posted>
  <last_update_submitted>September 11, 2017</last_update_submitted>
  <last_update_submitted_qc>September 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>moxibustion</keyword>
  <keyword>irritable bowel syndrome</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Irritable Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

